SC 13G: Monopar Therapeutics
Ticker: MNPR · Form: SC 13G · Filed: 2024-10-24T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Monopar Therapeutics.
Risk Assessment
Risk Level: low
From the Filing
0001214659-24-017900.txt : 20241024 0001214659-24-017900.hdr.sgml : 20241024 20241024160822 ACCESSION NUMBER: 0001214659-24-017900 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20241024 DATE AS OF CHANGE: 20241024 GROUP MEMBERS: KEVIN TANG GROUP MEMBERS: TANG CAPITAL PARTNERS III, INC GROUP MEMBERS: TANG CAPITAL PARTNERS IV, INC GROUP MEMBERS: TANG CAPITAL PARTNERS, LP SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-94081 FILM NUMBER: 241392705 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001232621 ORGANIZATION NAME: IRS NUMBER: 461592449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-200-3830 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 SC 13G 1 mnpr1024240sc13.htm Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Monopar Therapeutics Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 61023L207 (CUSIP Number) October 24, 2024 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13d-1(b) x Rule 13d-1(c) ¨ Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 10 Pages CUSIP No. 61023L207 13G Page 2 of 10 Pages 1 NameS of Reporting Persons I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY) Tang Capital Management, LLC 2 Check the Appropriate Box if a Member of a Group* ( a ) ☐ ( b ) ☐ 3 SEC Use Only 4 Citizenship or Place of Organization DELAWARE Number of Shares BENEFICIALLY Owned by Each Reporting Person with 5 Sole Voting Power 0 6 Shared Voting Power 200,000 7 Sole Dispositive Power 0 8 Shared Dispositive Power 200,000 9 Aggregate Amount Beneficially Owned by each Reporting Person 200,000 10 Check Box if the Aggregate Amount in Row (9) excludes certain shares ¨ 11 Percent of Class represented by amount in row 9 5.1% 12 type of reporting person OO Page 2 of 10 Pages CUSIP No. 61023L207 13G Page 3 of 10 Pages 1 NameS of Reporting Persons I.R.S. Identification NOS. of Above Persons (ENTITIES ONLY) Kevin Tang 2 Check the Appropriate Box if a Member of a Group* ( a ) ☐ ( b ) ☐ 3 SEC Use Only 4 Citizenship or Place of Organization united states Number of Shares BENEFICIALLY Owned by Each Reporting Person with 5 Sole Voting Power 0 6 Shared Voting Power 200,000 7 Sole Dispositive Power 0 8 Shared Dispositive Power 200,000 9 Aggregate Amount Beneficially Owned by each Reporting Person 200,000 10 Check Box if the Aggregate Amount in Row (9) excludes certain shares ¨ 11 Percent of Cla